[e-drug] Drug Policy Issues 2000 Beirut Lebanon Oct 29-Nov 10

[richardl@bu.edu]

E-drug: Drug Policy Issues 2000 Beirut Lebanon Oct 29-Nov 10
-------------------------------------------------------------------------

Hi E-Druggers,

I am happy to announce the next Drug Policy Issues Course for 2000

To apply electronically go to:
 http://www.bumc.bu.edu/Departments/PageMain.asp?Page=2025&DepartmentID=82

otherwise send an e-mail to Tammy Willcox at tlwc@bu.edu

***************************************************************************
Boston University School of Public Health Center for International Health 
And 
the Inter-Ministerial Council For Health Reform in Lebanon 
in Collaboration with 
the World Health Organization 
present
Drug Policy Issues for Developing and Transitional Countries
October 29 - November 10, 2000
Beirut, Lebanon

Course Overview

This two-week seminar is intended for policy makers and senior managers
responsible for pharmaceutical systems in developing countries, and for
senior officials of funding agencies.
The faculty is drawn from universities, the World Health Organization, and
from universities in the United States, South Africa, and Lebanon.
The seminar's workshop format will combine lectures, in-depth discussion of
case studies, field trips, and small-group exercises. 
Enrollment is limited to facilitate maximum interaction among participants
and between participants and faculty. 
The seminar will take place at two venues, one in Beirut and the other in
the hills overlooking City of Beirut.  There will be several field visits to
hospitals and other health facilities and to community pharmacies.
Previous seminars have been held in USA, Africa, and India.

Over the last 15 years, developing and transitional countries around the
world have adopted essential drug lists, national formularies, and standard
treatment guidelines. But national drug policies require more than drug
lists; hard choices have to be made. 
In procurement and production, economies of scale often conflict with
support of domestic industries and protection of national sovereignty. Some
countries are privatizing aspects of their pharmaceutical services.
Controversy over regulation involves fundamental questions about trade
policy and intersectoral collaboration. 
Once supply mechanisms function smoothly, rational use demands sustained
attention. How can we ensure that drugs are prescribed and used
appropriately? Is it possible to change ingrained usage patterns? Finally,
what methods most effectively assess how well a country's drug policy is
functioning?
The seminar will address these and other issues intensively. The highly
experienced and knowledgeable faculty will present up-to-date information
and examine the implications of alternative policy approaches. 
Participants will also gain valuable insights from each other's experiences
and challenges.

Seminar Topics
	Indicators for Monitoring and Evaluating National Drug Policies and
Access to Drugs
Alternative approaches to assessment and monitoring. Use of different
indicators
	Developing and Implementing a National Drug Policy
Alternative methods of developing and implementing a national drug policy.
Components of drug policy. Case studies.
	Selection of drugs in Formularies, and Treatment Guidelines
How different countries have developed essential drug lists, national
formularies, and treatment guidelines.
	Procurement Issues
Procurement issues and options. Discussion of World Bank papers on drug
procurement. Market intelligence sources of information.
	Quality Assurance
Different approaches to assuring quality in procurement, production, and use
of drugs.
	Financing and Pharmaco-economic Issues
Insurance, revolving funds, fee-for-service, and other financing options.
The privatization option.
	Impact of Global trade treaties
Trade and protection issues, including the TRIPS agreement and WTO.
	Human Resource Planning and Development
Assessing the numbers and training needs of pharmacists and pharmacy
technicians.
	Consumer Issues
Involving consumers in improving their access and use of drugs.
	Promoting Rational Use of Drugs
Measuring and changing usage patterns. Policy implications of recent
intervention studies on methods to improve drug use.  Hospital Drug and
Therapeutic Committees.
	Drug Policies and Public Health
Effect on drug policies of such changes in public health as AIDS, TB,
Decentralization, Health Sector Reform.

Faculty

Edelisa Carandang
Medical Officer, Department of Essential Drugs and Other Medicines (WHO/EDM)
Marthe Everard
Pharmacist, Department of Essential Drugs and Other Medicines (WHO/EDM)
David Henry
Professor of Clinical Pharmacology, University of Newcastle, Australia
Hans Hogerzeil
Team Coordinator, Policy, Access and Rational Drug Use, Department of
Essential Drugs and Other Medicines (WHO/EDM/PAR)
Richard Laing
Associate Director, Center for International Health, Boston University
School of Public Health 
Zafar Mirza 
Executive Coordinator, Association for Rational use of Medication in
Pakistan (The Network)
Jonathan Quick, 
Director, Department of Essential Drugs and Other Medicines (WHO/EDM)
Budiono Santoso 
Professor of Clinical Pharmacology, Gadjah Mada University Yogyakarta
Indonesia, Regional Adviser Western Pacific Regional Office WHO
Rob Summers
Head, School Pharmacy, and Director, Faculty of Pharmacy, (MEDUNSA), South
Africa
Minor Changes made be made in the Faculty. 

Course Directors
Richard Laing 
Associate Director, Center for International Health
Abir Makarem
National Program Officer Pharmaceutical Issues WHO, Lebanon

Seminar Format

The seminar will meet from 9 a.m. to 4:30 p.m., Monday through Friday, with
one afternoon free weekly. There will be brief morning and afternoon breaks
and a 90-minute lunch break.

Dr. Laing and Dr. Abir Makarem, the seminar directors, will attend all
sessions to provide continuity. They and other faculty members will be
available to meet with participants individually and in small groups in the
evening. There will be field visits to hospitals, urban and private health
facilities and to community pharmacies. 
Participants will be awarded a certificate upon successful completion of the
seminar.

Housing
Hotel accommodations will be provided within both seminar sites, one located
in Beirut and the other in a scenic setting in the hills of Lebanon. Both
venues are attractive, comfortable, and well equipped, offering suitable
settings for fruitful after-hours discussions.
Accommodation will be provided in double rooms.  A single room will entail
extra payment.  All meals and local travel are included in the course fee.

Climate
Daytime temperature averages 15 to 20 degrees.

Fees
$3,200 Tuition and materials, shared housing, meals, and local
transportation.  Participants requiring an individual room will be charged
an additional $300.

Insurance
No medical insurance is included in the seminar fee. Participants are
encouraged to obtain their own medical insurance.

Visa Requirements
Participants should inquire whether a Visa is required and obtain this
before coming.

Richard Laing
Associate Professor of International Health
Boston University School of Public Health
715 Albany St, T4W, Boston MA 02118 USA
Tel 617 414-1444 Fax 617 638-4476
E-mail richardl@bu.edu

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.